Síndrome de Miller Fisher: efecto adverso de dosis de refuerzo para COVID-19

INTRODUCTION: The SARS-CoV-2 coronavirus has been a challenge for public health, establishing the vaccine as the best tool for its prevention. CLINICAL CASE: We present the case of a patient in whom Miller Fisher syndrome was documented after receiving her booster dose with the Oxford-AstraZeneca va...

Descripción completa

Detalles Bibliográficos
Autores principales: Díaz, María, Melendez, Miguel, Torres, Laura, Gutiérrez, Julian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Neurológica Argentina. Published by Elsevier España, S.L.U. 2022
Materias:
Caso Clínico
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477964/
http://dx.doi.org/10.1016/j.neuarg.2022.08.001
_version_ 1784790477999964160
author Díaz, María
Melendez, Miguel
Torres, Laura
Gutiérrez, Julian
author_facet Díaz, María
Melendez, Miguel
Torres, Laura
Gutiérrez, Julian
author_sort Díaz, María
collection PubMed
description INTRODUCTION: The SARS-CoV-2 coronavirus has been a challenge for public health, establishing the vaccine as the best tool for its prevention. CLINICAL CASE: We present the case of a patient in whom Miller Fisher syndrome was documented after receiving her booster dose with the Oxford-AstraZeneca vaccine. CONCLUSION: At the moment, a causal relationship between vaccination against COVID-19 and the development of Miller Fisher syndrome cannot be established, but knowledge of this potential adverse effect is relevant for early diagnosis and timely treatment.
format Online
Article
Text
id pubmed-9477964
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Sociedad Neurológica Argentina. Published by Elsevier España, S.L.U.
record_format MEDLINE/PubMed
spelling pubmed-94779642022-09-16 Síndrome de Miller Fisher: efecto adverso de dosis de refuerzo para COVID-19 Díaz, María Melendez, Miguel Torres, Laura Gutiérrez, Julian Neurología Argentina Caso Clínico INTRODUCTION: The SARS-CoV-2 coronavirus has been a challenge for public health, establishing the vaccine as the best tool for its prevention. CLINICAL CASE: We present the case of a patient in whom Miller Fisher syndrome was documented after receiving her booster dose with the Oxford-AstraZeneca vaccine. CONCLUSION: At the moment, a causal relationship between vaccination against COVID-19 and the development of Miller Fisher syndrome cannot be established, but knowledge of this potential adverse effect is relevant for early diagnosis and timely treatment. Sociedad Neurológica Argentina. Published by Elsevier España, S.L.U. 2022 2022-09-16 /pmc/articles/PMC9477964/ http://dx.doi.org/10.1016/j.neuarg.2022.08.001 Text en © 2022 Sociedad Neurológica Argentina. Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Caso Clínico
Díaz, María
Melendez, Miguel
Torres, Laura
Gutiérrez, Julian
Síndrome de Miller Fisher: efecto adverso de dosis de refuerzo para COVID-19
title Síndrome de Miller Fisher: efecto adverso de dosis de refuerzo para COVID-19
title_full Síndrome de Miller Fisher: efecto adverso de dosis de refuerzo para COVID-19
title_fullStr Síndrome de Miller Fisher: efecto adverso de dosis de refuerzo para COVID-19
title_full_unstemmed Síndrome de Miller Fisher: efecto adverso de dosis de refuerzo para COVID-19
title_short Síndrome de Miller Fisher: efecto adverso de dosis de refuerzo para COVID-19
title_sort síndrome de miller fisher: efecto adverso de dosis de refuerzo para covid-19
topic Caso Clínico
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477964/
http://dx.doi.org/10.1016/j.neuarg.2022.08.001
work_keys_str_mv AT diazmaria sindromedemillerfisherefectoadversodedosisderefuerzoparacovid19
AT melendezmiguel sindromedemillerfisherefectoadversodedosisderefuerzoparacovid19
AT torreslaura sindromedemillerfisherefectoadversodedosisderefuerzoparacovid19
AT gutierrezjulian sindromedemillerfisherefectoadversodedosisderefuerzoparacovid19

Ejemplares similares